Cutler Group LP Cara Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Jan 18, 2022	SELL	$11.99 - $18.14 $14,388 - $21,768	-1,200 Reduced 75.0%	400 $1,000
Q3 2021 Oct 26, 2021	BUY	$11.55 - $16.06 $3,465 - $4,818	300 Added 23.08%	1,600 $0
Q2 2021 Jul 19, 2021	BUY	$12.38 - $29.19 $16,094 - $37,947	1,300 New	1,300 $3,000
Q3 2020 Oct 27, 2020	SELL	$12.34 - $17.92 $49,360 - $71,680	-4,000 Closed	0 $0
Q1 2020 May 07, 2020	SELL	$9.12 - $17.78 $196,079 - $382,270	-21,500 Reduced 84.31%	4,000 $32,000
Q2 2019 Aug 09, 2019	BUY	$17.68 - $21.57 $434,928 - $530,622	24,600 Added 2733.33%	25,500 $3,000
Q3 2018 Nov 07, 2018	SELL	$17.57 - $23.95 $124,747 - $170,045	-7,100 Reduced 88.75%	900 $1,000
Q2 2018 Aug 10, 2018	BUY	$11.6 - $19.27 $81,200 - $134,890	7,000 Added 700.0%	8,000 $5,000
Q1 2018 May 11, 2018	SELL	$11.77 - $16.08 $57,673 - $78,791	-4,900 Reduced 83.05%	1,000 $8,000
Q4 2017 Jan 17, 2018	SELL	$11.86 - $14.08 $52,184 - $61,952	-4,400 Reduced 42.72%	5,900 $28,000
Q3 2017 Oct 17, 2017	BUY	$12.6 - $16.34 $129,780 - $168,302	10,300	10,300 $22,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $15M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.